On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.

The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on allegations that vaccine testing results were delayed until after the 2020 ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

Misinformation about ivermectin took hold during the Covid-19 pandemic and continues to circulate despite medical experts ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

The World Health Organization’s pandemic agreement represents a powerful commitment to global health and security, writes Nina Schwalbe In April in Geneva, as the US withdrew from engagement in global ...

Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73 (95% confidence interval, 0.56 to 0.96) compared to ...

While incidence of community-associated and healthcare-associated community-onset MRSA bacteremia declined during the ...

a. Vaxart is at risk of being delisted from Nasdaq since the Company's share price is not in compliance with their minimum $1.00 bid price requirement. A reverse split of the Company's common stock ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.